Drug Safety Alerts

ATTENTION (ALERT)!

Voluntary Recall of Tablet JUMEX 5mg (Selegline HCL) Batch No. 7V001, Registration No. 0101215 by M/S Sanofi Aventis Pakistan Limited

The Drug Regulatory Authority of Pakistan has issued a notification of Tablet JUMEX 5mg (Selegline HCL) Batch No. 7V001 by Manufacturer, used in Parkinson’s disease. This batch of drug does not meet appropriate quality standards and specifications. All concerned are intimated to keep caution in procurement, dispensation, promotion and immediately stop the usage/sale of this medicine.

Drug Safety Alerts,

Provincial Drug Control Unit,

Primary & Secondary Healthcare Department,

Govt. of the Punjab